Document is current
Any future updates will be listed below
-
Authors
Robinson, Stephen David https://orcid.org/0000-0003-0623-4636
Samuels, Mark https://orcid.org/0000-0002-9299-8343
Jones, William https://orcid.org/0000-0002-1332-6400
Stewart, Nicolas https://orcid.org/0000-0002-8969-4242
Eravci, Murat https://orcid.org/0000-0003-4786-9179
Mazarakis, Nektarios K https://orcid.org/0000-0002-4128-8755
Gilbert, Duncan https://orcid.org/0000-0003-1859-7012
Critchley, Giles https://orcid.org/0009-0008-2628-8176
Giamas, Georgios https://orcid.org/0000-0002-4417-2707
-
Funding
Funding for this research was provided by:
University Hospitals Sussex NHS Foundation Trust Medical Doctoral Fellowship
- License Information
-
More Information
Article History
Received: 28 February 2024
Accepted: 21 June 2024
First Online: 1 July 2024
Declarations
:
: All experimental protocols were approved by the University of Sussex Research Ethics Committee (reference: ER/BSMS2229/1). Each participant provided written informed consent to take part in this research.
: Not applicable.
: Georgios Giamas is the founder and chief scientific officer of Stingray Bio. The rest of the authors declare that they have no relevant financial or non-financial interests to disclose.
